Skip to main content

eFFECTOR Therapeutics Inc. Common Stock (EFTR)

About The Company

EFTR Stock Market Logo

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California.

IPO Year Sector Industry
2021 Health Care Biotechnology: Pharmaceutical Preparations

eFFECTOR Therapeutics Inc. (EFTR) Latest News

Company Contact & Address (EFTR)

Corporate Headquarters Phone Website
United States
+1 858 925-8215 Official EFTR Website

EFTR Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ EFTR

Jobs & Employment at eFFECTOR Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page Jobs, Employment & Careers at eFFECTOR Therapeutics Inc. (EFTR)

Related & Similar Stock Symbols

HYLN Stock Market Price & News


Hyliion Holdings Corp. Class A Common Stock

JHAA Stock Market Price & News


Nuveen Corporate Income 2023 Target Term Fund

VSH Stock Market Price & News


Vishay Intertechnology Inc. Common Stock